Agence nationale de sécurité du médicament et des produits de santé (ANSM), France, conducted a Good Manufacturing Practices (GMP) inspection of Cenexi's Fontenay Manufacturing Facility (material subsidiary of Gland Pharma Limited) between December 9th to 19th, 2024.
The said inspection was concluded, and the Facility received an official notification on December 24, 2024, citing 10 (TEN) observations. Cenexi is committed to working closely with the ANSM to address the Observations and will provide further updates to the exchanges as they become available.
Shares of Gland Pharma Limited was last trading in BSE at Rs. 1825.50 as compared to the previous close of Rs. 1779.90. The total number of shares traded during the day was 34454 in over 2897 trades.
The stock hit an intraday high of Rs. 1832.60 and intraday low of 1736.65. The net turnover during the day was Rs. 62189214.00. |
